Loading clinical trials...

A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population | Clinical Trials | Clareo Health

COMPLETED

A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population

A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population Aged 2 Years and Above

NCT07071701•Sinovac Biotech Co., Ltd

View on ClinicalTrials.gov

Summary

An open clinical trial of a 23-valent pneumococcal polysaccharide vaccine (PPV23) developed by Sinovac Life Science Co., Ltd was conducted to evaluate the safety of Sinovac PPV23 in target population of individuals aged 2 years and above. All participants received 1 dose of PPV23 and self-selected whether to receive 1 dose of influenza vaccine at the same time.

Eligibility

Age

2 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Have voluntarily and at their own expense received the 23-valent pneumococcal polysaccharide vaccine;
•Participants and/or their guardians are able to understand and voluntarily participate in this study and sign an informed consent form;
•Provide valid legal identification.

Locations (1)

Jiangsu Provincial Center for Disease Prevention and Control

Nanjing, Jiangsu, China

Key Dates

Start Date

July 2, 2022

Primary Completion Date

April 5, 2024

Completion Date

April 5, 2024

Last Updated

July 17, 2025

Enrollment

19,267

ACTUAL participants

Conditions

Pneumococcal Infectious Disease

Interventions

23-valent pneumococcal polysaccharide vaccine

BIOLOGICAL

Influenza vaccine

BIOLOGICAL

Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years

NCT06675032

Pneumococcal Infectious Disease

View study

COMPLETEDPHASE3

Safety and Immunogenicity of a Newly 23-valent Pneumococcal Polysaccharide Vaccine in Chinese Adults and Children

NCT02285036

Pneumococcal Infectious Diseases

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 17, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions